Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong

FTT Lai, L Huang, CSL Chui, EYF Wan, X Li… - Nature …, 2022 - nature.com
Prior research using electronic health records for Covid-19 vaccine safety monitoring
typically focuses on specific disease groups and excludes individuals with multimorbidity …

Analysis of COVID-19 vaccine type and adverse effects following vaccination

AL Beatty, ND Peyser, XE Butcher… - JAMA network …, 2021 - jamanetwork.com
Importance Little is known about the factors associated with COVID-19 vaccine adverse
effects in a real-world population. Objective To evaluate factors potentially associated with …

[HTML][HTML] COVID-19 vaccination and non–COVID-19 mortality risk—seven integrated health care organizations, United States, December 14, 2020–July 31, 2021

S Xu - MMWR. Morbidity and Mortality Weekly Report, 2021 - cdc.gov
COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care
Organizations, United States, December 14, 2020–July 31, 2021 | MMWR Skip directly to site …

Description of frequencies of reported adverse events following immunization among four different COVID-19 vaccine brands

A Kant, J Jansen, L van Balveren, F van Hunsel - Drug safety, 2022 - Springer
Introduction The rapid rollout of coronavirus disease 2019 (COVID-19) vaccines for a large
proportion of the population necessitates a strong emphasis on safety. Complementary to …

[HTML][HTML] A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination

S Xu, R Huang, LS Sy, V Hong, SC Glenn, DS Ryan… - Vaccine, 2023 - Elsevier
Background The safety of COVID-19 vaccines plays an important role in addressing vaccine
hesitancy. We conducted a large cohort study to evaluate the risk of non-COVID-19 mortality …

Age and gender disparities in adverse events following COVID-19 vaccination: Real-world evidence based on big data for risk management

X Xiong, J Yuan, M Li, B Jiang, ZK Lu - Frontiers in medicine, 2021 - frontiersin.org
Background: Two coronavirus disease 2019 (COVID-19) vaccines have received
emergency use authorizations in the US However, the safety of these vaccines in the real …

[HTML][HTML] COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated …

K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips… - Vaccine, 2024 - Elsevier
Abstract Background The Global COVID Vaccine Safety (GCoVS) Project, established in
2021 under the multinational Global Vaccine Data Network™(GVDN®), facilitates …

[HTML][HTML] Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study

X Li, A Ostropolets, R Makadia, A Shaoibi, G Rao… - Medrxiv, 2021 - ncbi.nlm.nih.gov
Background As large-scale immunization programs against COVID-19 proceed around the
world, safety signals will emerge that need rapid evaluation. We report population-based …

The safety profile of COVID-19 vaccinations in the United States

A Singh, R Khillan, Y Mishra, S Khurana - American journal of infection …, 2022 - Elsevier
Abstract Background/Aim Pfizer-BioNTech, Moderna, and Johnson & Johnson's Janssen are
the 3 COVID-19 vaccines authorized for emergency use in the United States. This study …

US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

D Gubernot, A Jazwa, M Niu, J Baumblatt, J Gee… - Vaccine, 2021 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has had a devastating
impact on global health, and has resulted in an unprecedented, international collaborative …